Activation of Cholinergic Anti-Inflammatory Pathway Ameliorates Cerebral and Cardiac Dysfunction After Intracerebral

Yue Su1, Wei Zhang1, Ruoxi Zhang1

  • 1Department of Neurology, Tianjin Medical University General Hospital, Tianjin Neurological Institute, Key Laboratory of Post-Neurotrauma, Neurorepair, and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin, China.

Insights

Activation of alpha7 nicotinic acetylcholine receptor (α7nAChR) with PNU-282987 improves brain and heart function after intracerebral hemorrhage (ICH) by promoting autophagy and reducing inflammation.

Area of Science:

  • Neuroscience
  • Cardiovascular Medicine
  • Inflammation Research

Background:

  • Intracerebral hemorrhage (ICH) is a severe stroke subtype with high mortality and morbidity.
  • Inflammation and cardiovascular complications are key features of ICH.
  • The alpha7 nicotinic acetylcholine receptor (α7nAChR) pathway is known to modulate inflammation via the cholinergic anti-inflammatory pathway (CAIP).

Purpose of the Study:

  • To investigate whether activating α7nAChR can improve cerebral and cardiac dysfunction following ICH.
  • To explore the role of autophagy in the protective effects of α7nAChR activation after ICH.

Main Methods:

  • Male C57BL/6 mice underwent ICH induction and were treated with PNU-282987 (α7nAChR agonist), MLA (α7nAChR antagonist), or 3-MA (autophagy inhibitor).
  • Neurological function, brain edema, inflammation markers, autophagy proteins, blood-brain barrier integrity, and myocardial fibrosis were assessed.
  • Cardiac function was evaluated using echocardiography.

Main Results:

  • PNU-282987 treatment reduced inflammatory factors, repaired the blood-brain barrier, alleviated brain edema, and improved neurological function.
  • Activation of α7nAChR ameliorated cardiac dysfunction and reduced myocardial fibrosis.
  • PNU-282987 increased autophagy markers (LC3, Beclin) and decreased P62, indicating enhanced autophagy.

Conclusions:

  • Activation of α7nAChR promotes autophagy and reduces inflammation, thereby improving both cerebral and cardiac outcomes after ICH in mice.
  • PNU-282987 represents a potential therapeutic strategy for managing ICH-induced brain and heart damage.
Abstract